Status
Conditions
Treatments
About
Study of non-invasive transcutaneous auricular vagus nerve stimulation (taVNS) intervention to improve the reward motivation and response inhibition of major depression disorder and its brain network mechanism.
Full description
Anhedonia is the core symptom of MDD, which means they have deficits in processing rewards.MDD get lesser positive feelings than healthy controls from rewards as they could not use the reward outcome to update the value of a stimulus, which in consequence impedes their reward motivation or response inhibition and worsen their symptom. This study is dedicated to revealing how reward motivation or response inhibition ability could be intervened by taVNS intervention, which has been proven is highly relevant to reward motivation and response inhibition ability. Implementing a safer intervention of taVNS stimulation might help us to prove a better treatment for patients.
All patients underwent a medical evaluation that included physical examination and routine laboratory studies before and after taVNS stimulation treatment. Before and after the taVNS treatment, depression symptom of each participant was assessed by the Hamilton Depression Scale and the Beck Depression Self-Rating Scale. The anhedonia severity was evaluated by The Temporal Experience of Pleasure Scale, the Self-Report Apathy Evaluation Scale, the Positive Valence system scale and the Motivation and Pleasure Scale. The neuroimaging data are collected using event-related potentials during the effort reward task and stop signal task before and after the intervention. Patients were randomly allocated into an active group and a sham group. This study plans to enroll a minimum total sample size of 30 participants in active and sham group respectively according to the Power and Sample Size program. The decision to enroll a patient was always made prior to randomization. Each patient will be treated for 4 weeks with 25Hz taVNS. Each participant was interviewed in detail about the adverse event of the taVNS intervention during 10 days. Every participant should take part in the study voluntarily and sign an informed consent form before the study.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Meet the criteria of depression assessed by at least two psychiatrists according to the fifth version of Diagnostic and Statistical Manual of Mental Disorders.
The score of Hamilton Depression Rating Scale-17 is larger than 18 and the score of the Apathy Evaluation scale is lager than 37.
Patients were taking antidepressants--Selective Serotonin Reuptake Inhibitor(SSRIs) alone.
Age was between 18 to 60 year old. The education duration was at least 6 years.
The vision or corrected vision was normal.
Right handedness.
No treatment of rTMS, transcranial direct current stimulation, or electroconvulsive therapy before.
Exclusion criteria
History of significant head trauma or neurological disorders.
Alcohol or drug abuse.
Focal brain lesions.
History of seizure.
First degree relative with epilepsy, significant neurological illness or head trauma, endocrine disease.
Significant unstable medical condition.
Recent aggression or other forms of behavioral dyscontrol.
Left-handedness.
Pregnancy.
Current alcohol or drug abuse
Inability to provide informed consent.
Patients with contraindications or factors affecting imaging quality, such as pacemakers, cochlear implants, or hearts Cerebrovascular metal stent, and metal denture.
Primary purpose
Allocation
Interventional model
Masking
60 participants in 2 patient groups
Loading...
Central trial contact
Rong Ye, Phd; Fengqiong Yu, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal